These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6160377)

  • 1. E-type prostaglandins and interferons: yin-yang modulation of macrophage tumoricidal activity.
    Schultz RM
    Med Hypotheses; 1980 Aug; 6(8):831-43. PubMed ID: 6160377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series.
    Schultz RM; Pavlidis NA; Stylos WA; Chirigos MA
    Science; 1978 Oct; 202(4365):320-1. PubMed ID: 694537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulation by macrophages II. Separation of mouse peritoneal macrophages having tumoricidal and bactericidal activities and those secreting PGE and interleukin I.
    Hopper KE; Cahill JM
    J Reticuloendothel Soc; 1983 Jun; 33(6):443-56. PubMed ID: 6602218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E.
    Taffet SM; Russell SW
    J Immunol; 1981 Feb; 126(2):424-7. PubMed ID: 7451984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferons' role in the inductive process of macrophage tumoricidal activity.
    Schultz RM
    Ann Inst Pasteur Immunol (1985); 1986; 137C(2):201-2. PubMed ID: 3155364
    [No Abstract]   [Full Text] [Related]  

  • 6. Autocrine versus lymphocyte-dependent mechanisms for macrophage activation.
    Schultz RM
    Cell Signal; 1991; 3(6):515-22. PubMed ID: 1723892
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway.
    Paulnock DM; Lambert LE
    J Immunol; 1990 Jan; 144(2):765-73. PubMed ID: 2104906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow progenitors cultured in the presence of granulocyte-macrophage colony-stimulating factor versus macrophage colony-stimulating factor differentiate into macrophages with distinct tumoricidal capacities.
    Falk LA; Hogan MM; Vogel SN
    J Leukoc Biol; 1988 May; 43(5):471-6. PubMed ID: 3131473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic activity of interferon-treated macrophages studied by various inhibitors.
    Schultz RM; Pavlidis NA; Stylos WA; Chirigos MA
    Cancer Treat Rep; 1978 Nov; 62(11):1889-92. PubMed ID: 728906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus-induced suppression of macrophage-mediated tumoricidal activity in murine macrophages.
    Koff WC; Dunegan MA; Chakrabarty MK; Hampar B; Showalter SD
    Cancer Res; 1987 Mar; 47(6):1534-7. PubMed ID: 2434219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of macrophage tumoricidal activity by agents known to increase cellular cyclic AMP.
    Schultz RM; Pavlidis NA; Stoychkov JN; Chirigos MA
    Cell Immunol; 1979 Jan; 42(1):71-8. PubMed ID: 219958
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of macrophage lipids in regulating tumoricidal activity. II. Internal genetic and external physiologic regulatory factors controlling macrophage tumor cytotoxicity also control characteristic lipid changes associated with tumoricidal cells.
    Schlager SI; Meltzer MS
    Cell Immunol; 1983 Aug; 80(1):10-9. PubMed ID: 6872005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of C5a in the induction of tumoricidal activity in C3H/HeJ (Lpsd) and C3H/OuJ (Lpsn) macrophages.
    Hogan MM; Yancey KB; Vogel SN
    J Leukoc Biol; 1989 Dec; 46(6):565-70. PubMed ID: 2509612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynorphin and related opioid peptides enhance tumoricidal activity mediated by murine peritoneal macrophages.
    Foster JS; Moore RN
    J Leukoc Biol; 1987 Aug; 42(2):171-4. PubMed ID: 2439627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo modulation of macrophage tumoricidal activity: enhanced tumor cell killing by peritoneal macrophages from mice given injections of sodium periodate.
    Weinberg JB
    J Natl Cancer Inst; 1981 Mar; 66(3):529-33. PubMed ID: 6259399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokines and bacteria, that induce tumoricidal activity, trigger a different secretory response in macrophages.
    Keller R; Keist R; Frei K
    Eur J Immunol; 1990 Mar; 20(3):695-8. PubMed ID: 2108046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of major histocompatibility complex (MHC) expression by interferons and microbial agents. Independent regulation of MHC class II expression and induction of tumoricidal activity in bone marrow-derived mononuclear phagocytes.
    Keller R; Joller P; Keist R; Binz H; van der Meide PH
    Scand J Immunol; 1988 Jul; 28(1):113-21. PubMed ID: 2456605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive effect of interferon-beta on development of tumoricidal activity in mouse macrophages.
    Pace JL; MacKay RJ; Hayes MP
    J Leukoc Biol; 1987 Mar; 41(3):257-63. PubMed ID: 3104517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of calcium ionophore A23187-induced priming of bone marrow-derived macrophages for tumor cell killing: relationship to priming by interferon.
    Johnson HM; Torres BA
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5959-62. PubMed ID: 2412225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.